Telesis Bio Inc. Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Telesis Bio Inc. quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Telesis Bio Inc. Cost of Revenue for the quarter ending June 30, 2024 was $2.35M, a 15.2% increase year-over-year.
  • Telesis Bio Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $10.1M, a 7.58% decline year-over-year.
  • Telesis Bio Inc. annual Cost of Revenue for 2023 was $10.6M, a 10.8% decline from 2022.
  • Telesis Bio Inc. annual Cost of Revenue for 2022 was $11.8M, a 75.6% increase from 2021.
  • Telesis Bio Inc. annual Cost of Revenue for 2021 was $6.74M, a 129% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.6M -$1.28M -10.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $11.8M +$5.1M +75.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $6.74M +$3.79M +129% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $2.95M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.